BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shokrzadeh M, Mohammadpour A, Ghassemi-barghi N, Hoseini V, Abediankenari S, Tabari YS. METALLOTHIONEIN-2A (RS1610216&RS28366003) GENE POLYMORPHISMS AND THE RISK OF STOMACH ADENOCARCINOMA. Arq Gastroenterol 2019;56:367-71. [DOI: 10.1590/s0004-2803.201900000-69] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Ghassemi-Barghi N, Ehsanfar Z, Mohammadrezakhani O, Ashari S, Ghiabi S, Bayrami Z. Mechanistic Approach for Protective Effect of ARA290, a Specific Ligand for the Erythropoietin/CD131 Heteroreceptor, against Cisplatin-Induced Nephrotoxicity, the Involvement of Apoptosis and Inflammation Pathways. Inflammation 2022. [PMID: 36085231 DOI: 10.1007/s10753-022-01737-7] [Reference Citation Analysis]
2 Ahmadi Hedayati M, Khani D, Sheikhesmaeili F, Nouri B, Granito A. ptk2 and mt2a Genes Expression in Gastritis and Gastric Cancer Patients with Helicobacter pylori Infection. Canadian Journal of Gastroenterology and Hepatology 2022;2022:1-8. [DOI: 10.1155/2022/8699408] [Reference Citation Analysis]
3 Sekovanić A, Jurasović J, Piasek M. Metallothionein 2A gene polymorphisms in relation to diseases and trace element levels in humans. Arh Hig Rada Toksikol 2020;71:27-47. [PMID: 32597135 DOI: 10.2478/aiht-2020-71-3349] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
4 Shokrzadeh M, Goleij P, Behravan E, Ghassemi-Barghi N, Salehabadi Y, Rezaei A. ASSOCIATION BETWEEN DIABETICS AND INTESTINAL CANCER WITH THE RISK OF MUTATION IN CD38 GENE IN IRANIAN POPULATION. Arq Gastroenterol 2020;57:137-43. [PMID: 32490905 DOI: 10.1590/s0004-2803.202000000-25] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Wang J, Huang P, Zhao W, Ren W, Ai L, Wu L. Quantitative assessment of the association of polymorphisms in the metallothionein 2A gene with cancer risk. J Int Med Res 2020;48:300060520947937. [PMID: 32809904 DOI: 10.1177/0300060520947937] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Yang CC, Lin CI, Lee SS, Wang CL, Dai CY, Chuang HY. The association of blood lead levels and renal effects may be modified by genetic combinations of Metallothionein 1A 2A polymorphisms. Sci Rep 2020;10:9603. [PMID: 32541800 DOI: 10.1038/s41598-020-66645-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]